14 January 2025
Half-Yearly Report Games Workshop Group PLC (‘Games Workshop’ or the ‘Group’) announces its half-yearly results for the 26 week period ended 1 December 2024….
10 January 2025
GSK’s Shingrix new prefilled syringe presentation accepted for review by US FDA GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has…
Anpario plc (“Anpario”, the “Group” or the “Company”) Full year trading statement Anpario plc (AIM:ANP), the independent manufacturer of natural sustainable animal feed additives…
9 January 2025
GREGGS PLC (“Greggs” or the “Company”) Q4 TRADING UPDATE GOOD PROGRESS AND RECORD £2 BILLION SALES Q4 highlights * 52 weeks ended 28 December…
Harworth Group plc (“Harworth” or “the Group”) Harworth completes record 1,896 Residential plot sales in the fourth quarter of 2024 Harworth, a leading regenerator…
Henry Boot completes the sale of 632 plots in Coventry to Vistry Henry Boot announces that its land promotion and planning business, Hallam Land…
8 January 2025
The following is an update to the fourth quarter 2024 outlook and gives an overview of our current expectations for the fourth quarter. Outlooks…
7 January 2025
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives US FDA Breakthrough Therapy Designation in late-line relapsed or refractory osteosarcoma GSK plc (LSE/NYSE: GSK) announced today that…